spacer
home > pmps > autumn 2019 > hurdles in cold chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Hurdles in Cold Chain





One of the least known but most important aspects of the airfreight cold chain is airport ground handling. This provides the vital interface between airlines that carry temperaturecritical products and local ground transportation. Increasingly, ground handling is well resourced and carefully regulated, but thatís not the case everywhere in the world, and forwardthinking handlers and airports are trying to set examples that others will follow, recognising that the airfreight cold chain is only as strong as its weakest link.

It has been many years since the air cargo industry first started carrying temperature-critical pharmaceutical and life sciences shipments and, like so many other areas of business, it has been a steep learning curve that has driven innovation, the adoption of new technology, demand for higher standards, and greatly increased scrutiny.

The great advantage of airfreight is, of course, speed. With the ready availability of non-stop flights on every major world trade lane today, itís commonplace for an airfreight shipment to take no more than a day to cross the world Ė which is an appealing proposition for maintaining condition, achieving tight deadlines, and reducing capital tied up in inventory in transit.
 

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Paul Cheng is General Manager of Service Delivery at Hong Kong Air Cargo Terminals Limited (Hactl), managing operations at the largest single general air cargo handling facility in the world. An increasing proportion of Hactlís traffic is temperaturecritical pharmaceuticals, as well as large volumes of perishables that require similar special handling facilities and processes. Hactl is widely recognised as a leader in its industry and is regularly involved in the formulation of new standards, working in conjunction with industry and regulatory bodies.


Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

April 1, 2020 Ė ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits. ERTís At-Home Respiratory Solutions enable clinical trial sponsors to continue developing new respiratory treatments while patient access to investigative sites is limited due to COVID19 stay-at-home mandates.
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources youíve committed to post-approval research, you may be wondering if youíre getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement